Physician profile
Robert J Carney
NPI 1063407203
$9,465.98
in general payments reported to CMS, 2019-2025
35 companies · $1,105 in 2025
The $1,105 reported for 2025 was more than what a typical Cardiovascular Disease provider received nationally (typical 2025 total: $433).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,849 · 2020: $778 · 2021: $1,624 · 2022: $1,514 · 2023: $1,276 · 2024: $1,321 · 2025: $1,105.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $3,668 · Education: $33.66.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $3,667.62 |
| Education | $33.66 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Novartis Pharmaceuticals Corporation | $2,015.83 | 2019-2025 | |
| Merck Sharp & Dohme LLC | $898.00 | 2021-2025 | Verquvo, Capvaxive |
| Astrazeneca Pharmaceuticals LP | $837.96 | 2019-2025 | Farxiga, Lokelma |
| E.R. Squibb & Sons, L.L.C. | $705.48 | 2019-2025 | Camzyos, Eliquis |
| Pfizer INC. | $697.65 | 2019-2025 | |
| Amgen INC. | $655.73 | 2019-2025 | Repatha, Repatha |
| Janssen Pharmaceuticals, INC | $630.31 | 2019-2023 | Xarelto |
| Medtronic, INC. | $586.99 | 2021-2023 | Onyx Frontier, Telescope |
| Sanofi-Aventis U.S. LLC | $302.09 | 2019-2023 | |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $294.20 | 2019-2025 | Lifevest |
| Shockwave Medical, INC | $206.30 | 2023-2025 | Shockwave Ivl System With The Shockwave C2 Coronary Ivl Catheter, Shockwave Ivl System With The Shockwave C2 Coronary Ivl Catheter |
| Esperion Therapeutics, INC. | $202.60 | 2021-2025 | Nexletol |
| Alnylam Pharmaceuticals INC. | $168.88 | 2021-2025 | Onpattro |
| Cvrx, INC. | $142.53 | 2022-2025 | Barostim Neo System |
| Boston Scientific Corporation | $142.03 | 2022-2025 | Rotapro |
Show all 35 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Boehringer Ingelheim Pharmaceuticals, INC. | $135.26 | 2019-2025 | Jardiance |
| Amarin Pharma, INC. | $128.19 | 2019-2021 | |
| Bayer Healthcare Pharmaceuticals INC. | $117.80 | 2021-2025 | |
| Novo Nordisk INC | $98.89 | 2022-2025 | Ozempic, Rybelsus, Wegovy |
| Abbott Laboratories | $66.27 | 2019-2021 | |
| Lundbeck LLC | $58.91 | 2020-2021 | |
| Lexicon Pharmaceuticals, INC. | $46.61 | 2024 | |
| Medtronic Vascular, INC. | $44.52 | 2019-2020 | |
| Philips North America LLC | $40.62 | 2022 | |
| Altathera Pharmaceuticals LLC | $37.24 | 2024 | Sotalol Hydrochloride |
| Kowa Pharmaceuticals America, INC. | $30.57 | 2019-2021 | |
| Biotronik INC. | $26.65 | 2024 | Amvia Edge, Acticor 7 Vr-T Dx |
| Irhythm Technologies, INC. | $24.06 | 2023 | Zio Xt Patch |
| Vifor Pharma, INC. | $23.53 | 2021 | |
| Kiniksa Pharmaceuticals International, Plc | $22.95 | 2024 | Arcalyst |
| Gilead Sciences, INC. | $18.76 | 2019 | |
| Kiniksa Pharmaceuticals, LTD. | $17.40 | 2021 | |
| Tactile Systems Technology INC | $16.62 | 2023 | Entre Plus, Flexitouch Plus |
| Surmodics, INC. | $12.93 | 2022 | |
| Arbor Pharmaceuticals, INC. | $11.62 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Robert Carney listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.